Lv1
70 积分 2022-09-14 加入
Primary testicular lymphoma
3天前
已完结
外周T细胞淋巴瘤的表观遗传学改变及药物研究进展
5天前
已完结
Impacts of early therapy response, interval to therapy interruption, and cumulative therapy interruption duration on outcome of ibrutinib therapy in relapsed/refractory chronic lymphocytic leukemia
6天前
已完结
Targeting epigenetic modifications as an emerging immunotherapeutic strategy for cancers
6天前
已完结
Epigenetic drugs in cancer therapy: mechanisms, immune modulation, and therapeutic applications
6天前
已关闭
Epigenetic Therapies
6天前
已完结
KRAS Inhibition in Non-Small Cell Lung Cancer with Central Nervous System Involvement: Current Evidence and Future Directions
25天前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
25天前
已完结
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
2个月前
已完结
The conundrum of drug development in higher-risk MDS: Lessons learned from recently failed phase 3 clinical trials
3个月前
已完结
皖公网安备34019202002308
